The global airway management devices market size was valued at USD 2.79 billion in 2025 and is projected to grow from USD 2.96 billion in 2026 to USD 4.80 billion by 2034, registering a CAGR of 6.21% during the forecast period from 2026 to 2034. North America dominated the airway management devices market with a market share of 38.6% in 2025.
Airway management devices are medical instruments designed to establish, maintain, and protect a patient's airway to ensure adequate ventilation and oxygen delivery during medical emergencies, surgical procedures, and critical care. These devices include endotracheal tubes, laryngeal masks, tracheostomy tubes, laryngoscopes, airway adjuncts, and resuscitation equipment. They are widely used in hospitals, ambulatory surgical centers, emergency medical services, and intensive care settings to support safe and effective respiratory management.
Download a Free Sample To learn more about this report,
Integration of Video Laryngoscopy With Advanced Imaging Technologies
The Airway Management Devices Market analysis shows that difficult airway situations require clearer visualization of laryngeal anatomy, which encourages manufacturers to combine video laryngoscopy with high-resolution cameras, improved optics, and digital image displays. This transition is improving visualization during intubation and supporting more controlled airway management, with the American Society of Anesthesiologists noting that video-assisted laryngoscopy can provide improved laryngeal views and higher first-attempt intubation success in difficult-airway patients. For example, the Medtronic McGRATH MAC uses a CMOS camera and a 2.4-inch LCD color display to provide a video view of the vocal cords during laryngoscopy.
Development of Single-Use and Disposable Airway Management Devices
Infection-control requirements and the need to simplify device reprocessing are encouraging healthcare providers to adopt single-use airway management devices and disposable laryngoscope components. This transition is reducing dependence on cleaning and sterilization between patients, resulting in faster device turnover and more consistent infection-control practices; the FDA notes that reusable laryngoscopes require multistep cleaning and disinfection or sterilization after use. For example, Medtronic's McGRATH MAC uses sterile disposable blades intended for single use, with blade sizes ranging from Macintosh 1 through 4 and X3.
Difficult Airway Management Solutions and Training Drive Market
The need to manage anatomically difficult airways creates demand for specialized devices that support safer and more reliable airway access. Patients with limited neck movement, restricted mouth opening, or complex airway anatomy may require alternative intubation approaches. For example, anesthesiologists may use flexible bronchoscopes or specialized supraglottic devices when conventional intubation is challenging. This clinical requirement supports demand for specialized airway equipment and encourages suppliers to broaden their product portfolios.
The need for hands-on airway management training creates demand for airway trainers, simulation systems, and compatible clinical devices. Medical schools and hospitals use simulation to develop clinician skills in intubation, ventilation, and emergency airway procedures. For example, anesthesia residents can practice endotracheal intubation on airway mannequins before performing the procedure on patients. This training activity supports recurring purchases of simulation equipment and provides suppliers with an additional institutional customer base.
Airway-Related Complications and Regulatory Requirements Restrain Market Expansion
Risks such as airway trauma, aspiration, difficult intubation, and device-related injury can create safety concerns during airway management procedures. These concerns increase the need for proper training, careful device selection, and clinical monitoring during use. The resulting safety considerations can reduce confidence in some devices and slow adoption, particularly in facilities with limited expertise.
Stringent regulatory requirements involve device classification, safety and performance testing, quality controls, and premarket review before eligible devices can enter the U.S. market. For example, FDA requires a 510(k) submission for applicable devices before marketing, while higher-risk Class III devices generally require the more rigorous PMA pathway. These requirements increase development and compliance burdens, which can delay product launches and slow market expansion.
Pediatric and Critical Care Airway Devices Offers Growth Opportunities
Development of Pediatric and Neonatal Airway Devices: Medical device manufacturers and hospitals can use specialized airway devices designed for the smaller anatomies of infants and children. WHO estimates that 13.4 million babies were born preterm in 2020, creating a substantial need for specialized neonatal care, while Medtronic already offers neonatal and pediatric airway devices. Such specialized products can support market growth through dedicated product portfolios and hospital procurement.
Adoption of Advanced Airway Devices in Critical Care Units: Hospitals, intensive care units, and medical device manufacturers can use specialized airway products for prolonged ventilation and complex critical-care procedures. Medtronic’s Shiley airway portfolio includes infant, pediatric, and adult sizes, with products indicated for general airway management and critical-care use. These applications create revenue through specialized devices and recurring hospital procurement, supporting market growth.
Skilled Workforce and Procurement Delays Hinders Growth
Shortage of Skilled Healthcare Professionals: Effective use of advanced airway devices requires clinicians with specialized training in intubation, ventilation, and difficult-airway management. WHO projects a global shortage of 11.1 million health workers by 2030, with shortages particularly concentrated in low- and middle-income regions. This workforce gap can limit device utilization, increase training requirements, and slow market expansion in underserved healthcare systems.
Product Availability and Hospital Procurement Delays: Hospitals often rely on structured procurement processes, budget approvals, and periodic purchasing cycles for medical devices, which can delay equipment replacement and adoption. WHO's procurement activities illustrate the scale and complexity of institutional healthcare purchasing, with procurement involving extensive supplier and product-management processes. Such delays can extend sales cycles, make demand forecasting less predictable, and slow revenue growth for airway-device manufacturers.
The supraglottic devices segment accounted for a share of 34.7% in 2025, owing to their widespread use in emergency care, anesthesia, and airway management procedures, along with ease of insertion and reduced invasiveness compared with certain traditional airway techniques. the growing adoption of supraglottic airway devices across hospitals and emergency medical settings further strengthens the segment’s dominant position in the airway management devices market.
The laryngoscopes segment is expected to grow at a CAGR of 6.97% during the forecast period, driven by increasing demand for efficient airway visualization, rising use of advanced laryngoscopy techniques, and growing adoption of video laryngoscopes in emergency and surgical settings. the infraglottic devices segment supports secure airway management through endotracheal intubation, while the resuscitators segment contributes to emergency ventilation and respiratory support during critical care procedures.
Request Customizationto receive a tailored report.
The anesthesia segment accounted for a share of 64.3% in 2025 due to the widespread use of airway management devices during surgical procedures, general anesthesia, and controlled ventilation. the growing volume of surgical procedures and increasing adoption of advanced airway management technologies in operating rooms further strengthen the segment’s dominant position in the airway management devices market.
The emergency medicine segment is expected to grow at a CAGR of 7.06% during the forecast period, fueled by increasing demand for rapid airway stabilization, rising emergency care volumes, and growing use of advanced airway devices in critical and life-threatening situations. the expansion of emergency departments, prehospital care services, and critical care infrastructure further supports the segment’s growth.
The hospitals segment accounted for a share of 86.4% in 2025, supported by the widespread use of airway management devices in surgical procedures, emergency care, intensive care, and critical respiratory support. the availability of specialized healthcare professionals, advanced medical infrastructure, and high patient volumes further strengthens the segment’s dominant position in the airway management devices market.
The home care segment is expected to grow at a CAGR of 7.21% during the forecast period, propelled by increasing demand for home-based respiratory care, rising prevalence of respiratory conditions, and growing adoption of portable airway management and ventilation devices. the expansion of home healthcare services and increasing preference for cost-effective and convenient patient care further supports the segment’s growth.
Speak to an Analystto discuss market opportunities.
The North America airway management devices market accounted for the largest regional share of 38.6% in 2025, driven by advanced healthcare infrastructure, high adoption of airway management technologies, and increasing demand for critical care and emergency medical services. The U.S. airway management devices market is supported by continued demand in emergency and critical-care settings, with millions of critically ill adults undergoing tracheal intubation each year in emergency departments and intensive care units. In addition, 2026 research is evaluating airway adjuncts and advanced techniques to improve the safety and effectiveness of emergency intubation.
The Canada airway management devices market is supported by Health Canada’s continued authorization and regulation of airway-related medical devices, including endotracheal tubes, tracheal intubation videoscopes, and fiberscopes. In 2026, Health Canada reported 481 new medical devices approved during April–June 2026, reflecting the continued introduction and availability of medical technologies within the Canadian healthcare system.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia-Pacific airway management devices market is expected to grow at a CAGR of 7.48%, showcasing the fastest-growing regional market, supported by expanding healthcare infrastructure, rising surgical procedures, and increasing adoption of advanced airway management devices. In Japan, the National Hospital Organization issued a 2026 procurement notice for an anesthesia system, with delivery scheduled by November 30, 2026, while Hiroshima University issued a September 2026 procurement notice for a general anesthesia system with delivery by May 31, 2027. These procurements indicate continued investment in anesthesia and airway-management infrastructure in Japanese hospitals.
China’s National Medical Products Administration oversees the new YY/T 0337-2025 standard for tracheal tubes and connectors, which is scheduled to take effect on October 1, 2026. The standard covers oral and nasal tracheal tubes and specialized tubes used for suction, monitoring, drug delivery, and other applications, supporting standardized safety and performance requirements for airway-management devices. In South Korea, the public procurement system has documented procurement of video laryngoscopes, including a 2026 specification for the McGRATH MAC video laryngoscope, which is designed for difficult-airway applications and endotracheal intubation, indicating continued adoption of advanced airway visualization technologies. In India, AIIMS New Delhi issued a 2026 tender for an integrated difficult airway scope, with the procurement covering one system and the bid process extending into September 2026, while another September 2026 procurement also covered an integrated difficult airway scope system, indicating continued investment in specialized airway-management equipment in major Indian hospitals.
The Europe airway management devices market accounted for a regional share of 27.4% in 2025, supported by established healthcare systems, growing demand for respiratory care, and increasing adoption of advanced airway management technologies. In the U.K. airway management devices market, NHS Supply Chain planned a national framework for medical simulation devices and technologies, including airway management trainers for resuscitation and advanced life-support training, with the procurement notice published in January 2026, indicating continued institutional demand for airway-management training equipment.
In the Germany airway management devices market, mandatory EUDAMED registration requirements took effect on May 28, 2026, for newly marketed medical devices, while products already marketed and continuing after that date must be registered by November 28, 2026. This regulatory requirement strengthens traceability for medical devices placed on the German market, including airway management devices. Meanwhile, the France airway management devices market is influenced by medical-device supply challenges, with France's Ministry of Health reporting that 11% of medical-device supply tension or shortage declarations concerned devices used in anesthesia and respiratory care. The country's 2025–2027 roadmap focuses on monitoring, preventing, and managing medical-device shortages, supporting efforts to maintain the availability of airway-management and respiratory devices.
The Middle East and Africa airway management devices market is expected to grow at a CAGR of 6.24%, supported by improving healthcare infrastructure, increasing access to critical care services, and rising demand for advanced medical devices. The UAE airway management devices market is expected to benefit from the continued expansion of healthcare capacity, with the Dubai Health Authority’s Dubai Clinical Services Capacity Plan 2022–2033 forecasting future healthcare demand and supply requirements and guiding investments in healthcare infrastructure and specialized services, supporting the need for medical equipment and devices used across hospitals and clinical care.
The Africa airway management devices market is expected to benefit from the WHO African Region’s 2026–2035 strategy to strengthen regulation, local production, and access to medical devices, alongside a new 2026–2030 emergency medical teams framework under which every African country is expected to have at least one functional national emergency medical team by 2030, requiring investment in standardized equipment and deployable medical infrastructure.
The airway management devices market is moderately fragmented, with medical device manufacturers, anesthesia equipment companies, respiratory care technology providers, airway management specialists, and regional healthcare equipment suppliers competing across hospitals, emergency care, ambulatory surgery, intensive care, and prehospital settings. Established players compete primarily on device safety, clinical efficacy, product reliability, ease of use, technological innovation, product range, regulatory compliance, manufacturing capabilities, distribution networks, and clinical support, with leading players such as Medtronic, Teleflex Incorporated, Ambu A/S, Verathon, and Smiths Group plc. estimated to account for approximately 45% of the global market based on their product portfolios, clinical applications, geographic presence, distribution networks, and competitive positioning.
Emerging and regional players within the airway management devices market ecosystem compete through cost-effective devices, specialized airway solutions, ergonomic designs, disposable and single-use products, customized offerings, localized distribution, flexible manufacturing, and rapid product development to address specific clinical requirements and strengthen their market presence. These players also focus on application-specific innovations, product customization, and localized support services to differentiate their offerings and expand their customer base.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Germany Surgical Equipment Market Size, Share and Forecast to 2034
Europe Surgical Equipment Market Size, Top Share and Forecast to 2034
Biofeedback Instrument Market Size, Share, Growth, Analysis, 2034
Cardiac Assist Devices Market Size, Share, Growth, 2034
Radiosurgery Market Size, Share, Growth, Analysis, Report, 2034
Interventional Cardiology Devices Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com